Your browser doesn't support javascript.
Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern.
Padilla-Rojas, Carlos; Jimenez-Vasquez, Victor; Hurtado, Veronica; Mestanza, Orson; Molina, Iris S; Barcena, Luis; Morales Ruiz, Sandra; Acedo, Steve; Lizarraga, Wendy; Bailon, Henri; Cáceres, Omar; Galarza, Marco; Rojas-Serrano, Nancy; Vargas-Herrera, Natalia; Lope-Pari, Priscila; Huayra, Joseph; Solari, Lely.
  • Padilla-Rojas C; Laboratorio de Referencia Nacional de Virus Respiratorios, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Jimenez-Vasquez V; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Hurtado V; Laboratorio de Referencia Nacional de Virus Respiratorios, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Mestanza O; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Molina IS; Laboratorio de Referencia Nacional de Virus Respiratorios, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Barcena L; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Morales Ruiz S; Laboratorio de Referencia Nacional de Biotecnologia y Biologia Molecular, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Acedo S; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Lizarraga W; Laboratorio de Referencia Nacional de Virus Respiratorios, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Bailon H; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Cáceres O; Laboratorio de Referencia Nacional de Virus Respiratorios, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Galarza M; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Rojas-Serrano N; Laboratorio de Referencia Nacional de Biotecnologia y Biologia Molecular, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Vargas-Herrera N; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Lope-Pari P; Laboratorio de Referencia Nacional de Biotecnologia y Biologia Molecular, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Huayra J; National Genomic Surveillance Program for SARS-CoV-2, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
  • Solari L; Laboratorio de Referencia Nacional de Virus Respiratorios, Centro Nacional de Salud Publica, Instituto Nacional de Salud Peru, Lima, Peru.
J Med Virol ; 93(12): 6845-6849, 2021 12.
Article in English | MEDLINE | ID: covidwho-1347416
ABSTRACT
The pandemic generated by SARS-Cov-2 has caused a large number of cases and deaths in the world, but South America has been one of the continents that were most hard hit. The appearance of new variants causes concern because of the possibility that they may evade the protection generated by vaccination campaigns, their greater capacity to be transmitted, or their higher virulence. We analyzed the circulating variants in Peru after improving our Genomic Surveillance program. The results indicate a steep increase of the lambda lineage (C.37) until becoming predominant between January and April 2021, despite the cocirculation of other variants of concern or interest. Lambda lineage deserves close monitoring and could probably become a variant of concern in the near future.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Genome, Viral / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: South America / Peru Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.27261

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Genome, Viral / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: South America / Peru Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.27261